市场调查报告书
商品编码
1423717
到 2030 年 DEXA(双能量 X 射线检测法)市场预测:按类型、技术、应用、最终用户和地区分類的全球分析Dual Energy X-ray Absorptiometry Market Forecasts to 2030 - Global Analysis By Type (Portable and Standalone), By Technology (Advanced Software, Artificial Intelligence (AI) and Other Technologies), Application, End User and By Geography |
根据 Stratistics 检测法 的数据,DEXA(双能)的全球市场预计将达到美元。
DEXA 是一种测量骨骼密度(BMD) 和身体组成的医学影像技术。使用两个X 射线能量水平,可以高精度、低辐射暴露地量化身体特定部位的骨量、脂肪量和瘦肉组织量,从而可以诊断骨质疏鬆症、评估骨折风险,并用于医疗和医疗保健。研究目的。可用于身体组成评估。
据世界卫生组织称,全球约有 4,100 万人(即 74%)死于非传染性疾病和慢性病。根据IOF的一项研究,亚洲骨质疏鬆和骨质缺乏症患者的数量预计到2020年将增加至2.866亿,到2050年将增加至5.333亿。
骨质疏鬆症和骨骼相关疾病的盛行率增加
骨质疏鬆症和骨骼相关疾病盛行率的增加是 DEXA(双能量 X 射线检测法)市场的关键驱动因素。人口老化和久坐的生活方式正在增加骨质疏鬆症的盛行率,因此需要早期诊断和监测。 DEXA 能够准确评估骨骼密度,有助于早期发现骨质疏鬆症,并及时进行干预以降低骨折风险。此外,管理骨骼健康的意识不断增强,并采取主动措施,全球对 DEXA 系统的需求不断增长,推动市场成长。
DEXA设备和维护高成本
获得 DEXA 设备的初始投资是巨大的,这阻碍了小型医疗机构和诊所采用该技术。此外,与设备维护、校准和软体更新相关的持续成本进一步增加了总体拥有成本,限制了可访问性和采用率,特别是对于预算有限的医疗机构而言,这阻碍了市场成长。
提高对骨骼健康和预防措施的认识
人们对骨质疏鬆症、骨折和相关骨病的认识不断提高,导致越来越多的人寻求早期诊断方法。这种意识促进了积极主动的医疗方法,并鼓励定期检查和骨骼密度评估。因此,医疗保健提供者和诊断中心对 DEXA 扫描的需求不断增长,越来越多的人优先考虑预防措施和早期检测以保持最佳的骨骼健康,从而推动市场成长。
辐射暴露问题和监管限制
辐射暴露问题和监管限制对市场构成重大威胁。儘管 DEXA 扫描通常涉及低剂量辐射暴露,但人们的担忧仍然存在,特别是对孕妇等敏感人群的频繁筛检和累积暴露。严格的辐射安全法规影响设备的使用和可近性。遵守严格的协议、辐射安全措施和培训要求增加了 DEXA 实施的复杂性和成本。此外,不断发展的法规可能需要持续的技术进步,以减少辐射,同时保持诊断准确性。
COVID-19 大流行造成骨骼密度扫描等非必要医疗程序的延误,从而扰乱了市场。由于诊所关闭、患者就诊减少以及医疗资源用于应对大流行病,DEXA 的获取受到限制。供应链中断影响了设备製造和分销,从而影响了市场成长。此外,患者对前往医疗机构就诊以及将基本医疗需求置于预防性检查之上的担忧加剧了大流行期间的市场动盪。
预计在预测期内,裂缝管理产业将是最大的
由于骨质疏鬆症相关骨折的增加,特别是在人口老化中,骨折治疗领域预计将在预测期内成为最大的领域。 DEXA 在评估骨骼健康和骨折风险以及指导骨折管理策略和治疗方面发挥重要作用。随着人们对预防性医疗保健的日益重视以及对早期发现骨骼相关问题的需求不断增加,预计骨折管理领域的市场将显着增长。
医院和诊所领域预计在预测期内复合年增长率最高
由于骨质疏鬆症和代谢疾病的诊断需求不断增加,医院和诊所预计在预测期内将呈现最高成长率。医院和诊所作为初级卫生保健中心,方便患者进行 DEXA 扫描以进行骨骼健康评估。此外,这些设施提供全面的医疗保健服务,对于骨骼密度筛检和身体组成分析至关重要,这对于各种医疗状况至关重要,并且正在推动该领域的成长。
由于老年人口不断增长、医疗基础设施改善以及骨质疏鬆症和相关疾病盛行率不断上升,亚太地区正在推动对 DEXA(双能量 X 射线检测法)系统的需求。此外,中国、印度和日本等国家医疗保健支出的增加、技术的进步和政府的支持措施正在促进该地区在 DEXA 市场的主导地位,并带来巨大的成长机会。
由于医疗保健支出增加、易患骨质疏鬆症的老年人口增加以及对预防性医疗保健的日益关注,预计北美地区将出现显着增长。此外,医疗保健基础设施的技术进步和主要市场参与者的存在也有助于该地区的成长潜力。此外,人们对骨骼健康意识的增强以及对早期诊断和治疗的重视进一步推动了 DEXA(双能量 X 射线检测法)系统在北美的采用。
According to Stratistics MRC, the Global Dual Energy X-ray Absorptiometry Market is accounted for $619.52 million in 2023 and is expected to reach $1207.26 million by 2030 growing at a CAGR of 10% during the forecast period. Dual-energy X-ray absorptiometry is a medical imaging technique that measures bone mineral density (BMD) and body composition. Using two X-ray energy levels, it quantifies the amount of bone, fat and lean tissue in specific body regions, aiding in diagnosing osteoporosis, assessing fracture risk, and evaluating body composition for medical or research purposes with high precision and low radiation exposure.
According to WHO, non-communicable diseases and chronic diseases account for around 41 Million deaths globally equivalent to 74%. According to IOF research, the number of individuals in Asia with osteoporosis and osteopenia is anticipated to climb to 286.6 million by 2020 and 533.3 million by 2050.
Increasing prevalence of osteoporosis and bone-related disorders
The increasing prevalence of osteoporosis and bone-related disorders acts as a significant driver in the dual-energy X-ray absorptiometry market. With an aging population and sedentary lifestyles, osteoporosis incidence rises, necessitating early diagnosis and monitoring. DEXA's precision in assessing bone mineral density aids in the early detection of osteoporosis, enabling timely intervention to mitigate fracture risks. Additionally, the expanding awareness and proactive measures to manage bone health contribute to the growing demand for DEXA systems globally, driving market growth.
High cost of DEXA equipment and maintenance
The initial investment for acquiring DEXA machines is substantial, deterring smaller healthcare facilities or clinics from adopting this technology. Additionally, ongoing expenses related to equipment maintenance, calibration and software updates further contribute to the overall cost of ownership, limiting accessibility and adoption, particularly for healthcare institutions with constrained budgets, thereby impeding market growth.
Growing awareness of bone health and preventative measures
Heightened consciousness regarding osteoporosis, fractures and related bone disorders prompts individuals to seek early diagnostic methods. This awareness fosters proactive healthcare approaches, encouraging regular screenings and bone density assessments. Consequently, healthcare providers and diagnostic centers witness heightened demand for DEXA scans, driving market growth as more people prioritize preventive measures and early detection to maintain optimal bone health.
Radiation exposure concerns and regulatory constraints
Radiation exposure concerns and regulatory constraints pose a significant threat to the market. While DEXA scans generally involve low radiation doses, concerns persist regarding cumulative exposure, especially in frequent screenings or for sensitive populations like pregnant women. Stringent regulations on radiation safety further impact device usage and accessibility. Compliance with strict protocols, radiation safety measures, and training requirements adds complexity and cost to DEXA implementation. Moreover, evolving regulations may demand continuous technological advancements to reduce radiation while maintaining diagnostic accuracy.
The COVID-19 pandemic disrupted the market by causing delays in non-essential medical procedures, including bone density scans. Clinic closures, reduced patient visits and diverted healthcare resources toward pandemic response limited DEXA utilization. Supply chain disruptions affected equipment manufacturing and distribution, impacting market growth. Moreover, patient concerns about visiting healthcare facilities and prioritizing essential medical needs over preventive screenings further contributed to the market disruption during the pandemic.
The fracture management segment is expected to be the largest during the forecast period
The fracture management segment is anticipated to lead during the forecast period due to rising cases of osteoporosis-related fractures, especially among aging populations. Dual Energy X-ray Absorptiometry plays a crucial role in assessing bone health and fracture risk and guiding fracture management strategies and treatments. With a growing emphasis on preventive healthcare and the need for early detection of bone-related issues, the fracture management segment is projected to witness substantial growth within the market.
The hospitals & clinics segment is expected to have the highest CAGR during the forecast period
The hospitals and clinics segment is anticipated to exhibit the highest growth rate during the forecast period due to increased diagnostic needs for osteoporosis and metabolic disorders. Hospitals and clinics serve as primary healthcare centers, facilitating patient access to DEXA scans for bone health assessments. Moreover, these facilities offer comprehensive healthcare services, making them pivotal for bone density screenings and body composition analyses, which are essential for various medical conditions, driving the segment's growth.
Asia Pacific is poised to lead in market share due to the region's expanding geriatric population, rising healthcare infrastructure and increasing prevalence of osteoporosis and related conditions, which drive the demand for Dual Energy X-ray Absorptiometry (DEXA) systems. Additionally, growing healthcare expenditure, technological advancements and supportive government initiatives in countries like China, India and Japan contribute to the region's dominance in the DEXA market, fostering substantial growth opportunities.
The North American region is poised for substantial growth owing to increasing healthcare expenditure, a rising geriatric population susceptible to osteoporosis and a growing emphasis on preventive healthcare. Additionally, technological advancements in healthcare infrastructure and the presence of key market players contribute to the region's growth potential. Moreover, heightened awareness about bone health and a strong focus on early diagnosis and treatment further drive the adoption of Dual Energy X-ray Absorptiometry systems in North America.
Key players in the market
Some of the key players in Dual Energy X-Ray Absorptiometry Market include Aurora Spine, BeamMed Ltd., Demetech AB, Diagnostic Medical Systems Group, Echolight S.p.A., Eurotec Medical Systems, Furuno Electric Co., Ltd., GE Healthcare, Hologic, Inc., Lone Oak Medical Technologies LLC, Medilink International, Medimaps Group, Osteometer Meditech Inc., OsteoSys Co., Ltd., SCANCO Medical AG, Shenzhen X-ray Equipment Co., Ltd. and Swissray Global Healthcare Holding Ltd.
In September 2023, Medimaps Group, a Swiss/Global med-tech company specializing in image-processing software with AI capabilities for assessing bone health, announced today it received the Medical Device Regulation (MDR) certification from its notified body BSI (CE 2797) for its management system and product portfolio.
In February 2022, Aurora Spine partnered with Echolight Medical, the manufacturer of the radiation-free EchoS portable densitometer utilized to assess the quality of the software platform and the bone mineral density (BMD) in the patients affected. The two companies decided to advertise one other's products to their respective clients and prospects as part of the Aurora DEXA Platform.
Other Technologies